97337 ⎘
Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
Transduction of gammadelta T cells with pseudotyped retroviral vectors
#2TAG72 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF TAG72-POSITIVE TUMORS
#3CIRCULAR RNAS FOR CELLULAR THERAPY
#4GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#5CAR FOR USE IN THE TREATMENT OF HVG DISEASE
#6CD33 TARGETED IMMUNOTHERAPIES
#7ADAPTER-BASED RETROVIRAL VECTOR SYSTEM FOR THE SELECTIVE TRANSDUCTION OF TARGET CELLS
#8NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS
#9VEGETATION MANAGEMENT SYSTEM AND VEGETATION MANAGEMENT METHOD
#10CLEC9A BINDING AGENTS
#11COMPOSITION AND METHOD FOR ADOPTIVE IMMUNOTHERAPY
#12CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN AND ENCODING POLYNUCLEOTIDES
#13MODULATION OF DENDRITIC CELL LINEAGES
#14Chimeric Antigen Receptor and Natural Killer Cells Expressing Same
#15DUAL-SPECIFIC BINDING MOLECULE USEFUL FOR ISOLATING SPECIFIC BLOOD CELLS
#16IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS
#17IMMUNE CELL FUNCTION
#18HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME
#19LIPID PARTICLES COMPRISING VARIANT PARAMYXOVIRUS ATTACHMENT GLYCOPROTEINS AND USES THEREOF
#20METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATASE ACTIVITY IN THE CNS
#21Regulatable Cell Surface Receptors and Related Compositions and Methods
#22CELLULAR IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF
#23CHIMERIC ANTIGEN RECEPTORS AGAINST MULTIPLE HLA-G ISOFORMS
#24Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy
#25METHODS AND COMPOSITIONS INVOLVING CHIMERIC BINDING POLYPEPTIDES
#26CD8 BINDING AGENTS
#27BISPECIFIC T CELL ENGAGERS
#28PSCA CAR-T CELLS
#29Use of Triplex CMV Vaccine in CAR T Cell Therapy
#30A REPLICATIVE ONCOLYTIC ADENOVIROUS CAPABLE OF INHIBITING TUMOR PROGRESSION AND PROLONGING SURVIVAL TIME IN TUMOR-BEARING INDIVIDUALS AND USE THEREOF
#31T CELL-TARGETED T CELLS
#32CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#33NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT
#34Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System
#35NPP1 Fusion Proteins
#36Compositions and Methods for Inhibiting T Cell Exhaustion
#37Compositions and Methods for Retrieving Tumor-related Antibodies and Antigens
#38Immune Cells Comprising Truncated NKG2D Chimeric Receptors
#39COMPOSITIONS AND METHODS FOR IMPROVED NK CELL THERAPIES
#40NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOF
#41Compositions and Methods for Retrieving Tumor-related Antibodies and Antigens
#42Panel comprising Borrelia MHC multimers
#43SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY
#44CD6 TARGETED CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF CERTAIN AUTOIMMUNE DISORDERS
#45Chimeric Antigen Receptor
#46ANTIBODY/T-CELL RECEPTOR CHIMERIC CONSTRUCTS AND USES THEREOF
#47New Interleukin-7 Immunoconjugates
#48TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
#49ANTIBODIES TO GALECTIN-3 AND METHODS OF USE THEREOF
#50CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION
#51COMBINATION THERAPY WITH TARGETED 4-1BB (CD137) AGONISTS
#52GENETICALLY MODIFIED CELLS AND USES THEREOF
#53Chimeric Antigen Receptors Targeting HER2
#54ICOS-L VARIANT WITH ENHANCED BINDING AFFINITY FOR ICOS
#55D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#56Primary NK CAR Constructs And Methods
#57METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY
#58EXPRESSION OF NOVEL CELL TAGS
#59CODON-OPTIMIZED NUCLEOTIDE SEQUENCES ENCODING AN AP-1 TRANSCRIPTION FACTOR
#60IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES THEREOF
#61COMPOSITIONS AND METHODS FOR GENERATING A PERSISTING POPULATION OF T CELLS USEFUL FOR THE TREATMENT OF CANCER
#62ROR1-SPECIFIC ANTIGEN BINDING MOLECULES
#63Compositions for Treating Pathological Calcification Conditions, and Methods Using Same
#64ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
#65ANTI-CD30 ANTIBODIES AND METHODS FOR TREATING CD30+ CANCER
#66ELIMINATION OF CD19-POSITIVE LYMPHOID MALIGNANCIES BY CD19-CAR EXPRESSING NK CELLS
#67POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY
#68Chimeric Antigen Receptor Molecule for Specifically Recognizing Baff-R and Application of Chimeric Antigen Receptor Molecule
#69TRUNCATED AND FUSION PROTEINS
#70METHODS AND COMPOSITIONS FOR TREATING CANCER
#71USE OF TRANS-SIGNALING APPROACH IN CHIMERIC ANTIGEN RECEPTORS
#72ICAM-1 TARGETED FUSION ENZYMES
#73METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
#74CHIMERIC RECEPTORS TARGETING ADGRE2 AND/OR CLEC12A AND USES THEREOF
#75CELLS AND COMPOSITIONS FOR TREATING CANCER
#76ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
#77BINDING-TRIGGERED TRANSCRIPTIONAL SWITCHES AND METHODS OF USE THEREOF
#78METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#79CAR LIBRARY AND scFv MANUFACTURING METHOD
#80CD229 Car T Cells And Methods Of Use Thereof
#81SYSTEMS AND METHODS FOR IMMUNOGENIC CELL DEATH APPLICATIONS
#82METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF IMMUNE CELLS
#83SYNCITIN-1 FUSION PROTEINS AND USES THEREOF FOR CARGO DELIVERY INTO TARGET CELLS
#84HEPATITIS B VACCINES AND USES OF THE SAME
#85ENGINEERED EXTRACELLULAR VESICLES FOR TARGETED DRUG DELIVERY TO MUSCLE
#86METHODS AND COMPOSITIONS FOR THERAPEUTIC PROTEIN DELIVERY
#87IL-21 POLYPEPTIDES AND TARGETED CONSTRUCTS
#88ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
#89CHIMERIC ANTIGEN RECEPTOR COMPRISING BCMA NANOBODY LINKED TO A CHIMERIC INTRACELLULAR SIGNALING DOMAIN
#90CD70 BINDING MOLECULES AND METHODS OF USE THEREOF
#91IL-18 POLYPEPTIDES FUSED TO IMMUNE CELL ANTIGEN SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF
#92COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#93ADENOVIRUS VECTORS AND METHODS FOR USING ADENOVIRUS VECTORS
#94COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY TARGETING FLT3, PD-1, AND/OR PD-L1
#95SYSTEMS AND METHODS FOR CHAPERONE-MEDIATED LIGAND EXCHANGE ON MHC-I AND MHC-RELATED MOLECULES USING CHICKEN TAPBPR
#96FUSOGENIC PEPTIDE COMPOSITIONS AND METHODS OF CARGO DELIVERY
#97ENGINEERED RECEPTORS SPECIFIC TO HLA-E AND METHODS OF USE
#98METHODS AND COMPOSITIONS FOR CAR T CELL THERAPY
#99HUMAN IgG Fc DOMAIN VARIANTS WITH IMPROVED EFFECTOR FUNCTION
#100EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS
#101COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES
#102DE NOVO DESIGN OF POTENT AND SELECTIVE INTERLEUKIN MIMETICS
#103MONOVALENT BLOOD BRAIN BARRIER SHUTTLE MODULES
#104HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS
#105GD2 CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#106CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER-FAMILY RECEPTORS
#107PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS
#108D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#109CHIMERIC ANTIGEN RECEPTORS TARGETING CD70
#110CYTOKINE FUSION PROTEIN
#111Therapeutic Biologic For Treatment Of Glioblastoma
#112COMPOSITIONS AND METHODS OF TREATING TISSUE DAMAGE
#113NOVEL INTERFERON VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF
#114GLYCOSYL-MODIFIED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND APPLICATIONS THEREOF
#115DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS
#116METHODS AND COMPOSITIONS COMPRISING B7H3 CHIMERIC ANTIGEN RECEPTORS
#117NKp46-Binding Polypeptides and Uses Thereof
#118CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF
#119BISPECIFIC RECOMBINANT PROTEIN AND USE THEREOF
#120CAR-TREG-BASED THERAPIES FOR TREATING NEURODEGENERATIVE DISEASES
#121INTERLEUKIN-2 MUTEINS, FUSION PROTEINS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS
#122MULTI-SPECIFIC BINDING MOLECULES TARGETING ABERRANT CELLS
#123AFFINITY-ENHANCED MONMERIC STREPTAVIDIN CHIMERIC ANTIGEN RECEPTOR (CAR)
#124COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
#125Gamma Delta T-Cell-Targeted Modified IL-2 Polypeptides and Uses Thereof
#126NOVEL CRISPR ENZYMES AND SYSTEMS
#127ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER
#128CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T) FOR THE TREATMENT OF CANCER
#129CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#130IMMUNOSUPPRESSIVE ANTIGEN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR TREG CELLS FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE AND ALLOIMMUNE DISORDERS
#131BAFF-R TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T-CELLS AND USES THEREOF
#132CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR INTERLEUKIN-23 RECEPTOR
#133Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy
#134METHODS AND COMPOSITIONS FOR DOSING OF ALLOGENEIC CHIMERIC ANTIGEN RECEPTOR T CELLS
#135Method of Redirecting T Cells to Treat HIV Infection
#136Transgenic Macrophages, Chimeric Antigen Receptors, and Associated Methods
#137COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#138CATENATED VAR2CSA RECOMBINANT PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF
#139FUSION MOLECULES AND IL-15 VARIANTS
#140A CONJUGATE FOR USE IN LOCALISING A MOLECULE TO THE VASCULAR ENDOTHELIUM
#141CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES THEREOF
#142ERYTHROCYTE-BINDING THERAPEUTICS
#143Immunosuppressive Antigen-Specific Chimeric Antigen Receptor Treg Cells for Prevention and/or Treatment of Autoimmune and Alloimmune Disorders
#144Interleukin 21 variants
#145ANTI-B7-H3 MONOCLONAL ANTIBODY AND USE THEREOF IN CELL THERAPY
#146CONSTITUTIVELY ACTIVE CHIMERIC CYTOKINE RECEPTORS
#147CELL TARGETING COMPOSITIONS AND METHODS
#148T Cell Modification and Use Thereof
#149METHODS AND COMPOSITIONS FOR TREATING HYPOPHOSPHATASIA
#150IL-21 POLYPEPTIDES AND TARGETED CONSTRUCTS
#151ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
#152IMMUNE CELL COMPOSITIONS AND METHODS OF USE
#153NUCLEIC ACID CONSTRUCTS FOR CO-EXPRESSION OF CHIMERIC ANTIGEN RECEPTOR AND TRANSCRIPTION FACTOR, CELLS CONTAINING AND THERAPEUTIC USE THEREOF
#154ANTIGEN-BINDING PROTEINS TARGETING MELANOMA DIFFERENTIATION ANTIGENS AND USES THEREOF
#155MULTIFUNCTIONAL IMMUNE CELL THERAPIES
#156METHODS AND COMPOSITIONS FOR MODULATING CAR-T ACTIVITY
#157KIDNEY TARGETED IMMUNOTOLERANCE
#158T-Cell Engaging Polypeptides and Methods of Use Thereof
#159PREPARATION OF ENGINEERED MYELOID CELLS
#160TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME
#161METHOD OF TREATING A TUMOR EXPRESSING CARBONIC ANHYDRASE IX (G250) BY ADMINISTERING A G250-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
#162COMPOSITIONS AND METHODS FOR IMPROVED T CELLS
#163ANTI-B7-H6 ANTIBODY, FUSION PROTEINS, AND METHODS OF USING THE SAME
#164Trispecific T cell Engagers
#165COMPOSITIONS AND METHODS THAT INHIBIT IL-23 SIGNALING
#166Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereof
#167MYOPEPTIDES AND METHODS OF USE IN TREATING HEART FAILURE
#168CHIMERIC ANTIGEN RECEPTOR WITH ENDOGENOUS PROTEIN MOLECULE REPLACING SINGLE DOMAIN ANTIBODY
#169BCMA CHIMERIC ANTIGEN RECEPTORS
#170T CELLS FOR EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS AND OTHER RECEPTORS
#171ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME
#172CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA AND METHODS OF USE THEREOF
#173MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES
#174METHODS FOR MAKING AND USING THERAPEUTIC CELLS
#175DHFR TUNABLE PROTEIN REGULATION
#176EFFECTIVE GENERATION OF TUMOR-TARGETED T CELLS DERIVED FROM PLURIPOTENT STEM CELLS
#177ANTIBODY-MEDIATED DELIVERY OF CAS9 TO MAMMALIAN CELLS
#178METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#179ANTI-CD30 ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR COMPRISING THEREOF
#180HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY
#181METHODS AND USES FOR NDFIP1 FUSION POLYPEPTIDES IN TREATING NEURODEGENERATIVE DISEASES, BRAIN AND/OR TRAUMATIC AND NON-TRAUMATIC SPINAL CORD INJURIES, AND/OR OPTIC NEUROPATHIES
#182ANTI-VARIABLE MUC1* ANTIBODIES AND USES THEREOF
#183MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
#184Engineered Expression of Cell Surface and Secreted Sialidase by CAR T Cells for Increased Efficacy in Solid Tumors
#185MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#186SALVAGE CHIMERIC ANTIGEN RECEPTOR SYSTEMS
#187COMPOSITIONS AND METHODS FOR TREATING HIV/AIDS WITH IMMUNOTHERAPY
#188MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
#189CHIMERIC ENGULFMENT RECEPTOR MOLECULES
#190Cell-Penetrating Peptides and Methods of Use Thereof
#191APPLICATION OF MULTIMER IN DETECTION AND PREPARATION OF CAR-EXPRESSING CELL
#192ANTIBODY
#193Targeted IL-12 Treatments and Methods to Stimulate haNK and NK92mi Cells
#194DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#195IMMUNOCONJUGATE MOLECULES AND RELATED METHODS AND COMPOSITIONS THEREOF
#196MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH
#197Anti-Abeta Therapeutic Vaccines
#198Bispecific T cell Engagers
#199TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY
#200ANTIBODY AGAINST GLYPICAN-3 AND APPLICATION THEREOF
#201TISSUE-DIRECTED ANTIBODIES AND METHODS OF USING THE SAME
#202Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
#203ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF
#204NOVEL CLDN 18.2-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
#205SULFATED POLYPEPTIDES FOR SYSTEMIC DELIVERY
#206METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF
#207ENGINEERED IMMUNE CELLS TARGETING BCMA AND THEIR USES THEREOF
#208METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATE ACTIVITY IN THE CNS
#209BUTYROPHILIN-LIKE 2 AGENTS FOR TREATING INFLAMMATORY DISORDERS
#210ICAM-1 targeted fusion enzymes
#211MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
#212VACCINE MOLECULES
#213MODIFIED IMMUNE CELL AND USE THEREOF
#214CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF
#215Anti-VEGF protein compositions and methods for producing the same
#216NK CELL ENGAGER MOLECULES AND METHODS OF USE
#217CORONAVIRUS VACCINE COMPRISING A MOSAIC PROTEIN
#218NOROVIRUS S PARTICLE BASED VACCINES AND METHODS OF MAKING AND USING SAME
#219NOVEL CHIMERIC RECEPTOR COMPOSITION, RECOMBINANT VECTOR, CELL, AND APPLICATION THEREOF
#220ENGINEERED MICROBE-TARGETING MOLECULES AND USES THEREOF
#221Anti-VEGF protein compositions and methods for producing the same
#222RETARGETED RETROVIRAL VECTORS RESISTANT TO VACCINE-INDUCED NEUTRALIZATION AND COMPOSITIONS OR METHODS OF USE THEREOF
#223COMPOSITIONS AND METHODS FOR TARGETING CD99-EXPRESSING CANCERS
#224TARGETING B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING LIGAND-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS
#225EXOSOME PACKAGING AND TARGETED AUTOPHAGY
#226RETARGETED RETROVIRAL VECTORS AND COMPOSITIONS OR METHODS OF USE THEREOF
#227ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS
#228CHIMERIC ANTIGEN RECEPTORS, COMPOSITIONS, AND METHODS
#229ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
#230Methods of Treating T Cell Exhaustion by Inhibiting or Modulating T Cell Receptor Signaling
#231AAV VECTOR VARIANTS FOR OCULAR GENE DELIVERY
#232ANTIBODY-NKG2D LIGAND DOMAIN FUSION PROTEIN
#233BAFF-R ANTIBODIES AND USES THEREOF
#234COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS
#235COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS
#236BIFUNCTIONAL COMPOUNDS CONTAINING IGF-2 POLYPEPTIDES
#237CHIMERIC PROTEINS FOR TARGETED DELIVERY OF GROWTH FACTORS TO THE GLOMERULUS
#238MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF
#239CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY
#240ERYTHROCYTE-BINDING THERAPEUTICS
#241RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#242RECOMBINANT PROTEIN HAVING FUSED INTERFERON-BETA MUTEIN AND ANTIBODY, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#243POLYPEPTIDES TARGETING CD70-POSITIVE CANCERS
#244ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER
#245COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY
#246PEPTIDES WITH MUCIN-BINDING PROPERTIES
#247GPRC5D CHIMERIC ANTIGEN RECEPTORS AND CELLS EXPRESSING THE SAME
#248BISPECIFIC NK CELL AGONIST, PREPARATION METHOD, AND APPLICATION
#249TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS
#250COMPOSITIONS AND METHODS FOR T-CELL AND CYTOKINE ACTIVATION
#251Method for Delivering Drug to Muscle
#252ANTIGEN BINDING POLYPEPTIDES
#253RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX
#254CELL-TARGETED CYTOTOXIC CONSTRUCTS
#255IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN
#256Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias
#257NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
#258THERAPEUTIC AGENTS
#259TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES
#260IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF
#261FUSION PROTEIN TARGETING PD-L1 AND NEUTRALIZING GAS6 AND USES THEREOF
#262USE OF CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS TO TREAT CANCER
#263FC-DERIVED POLYPEPTIDES
#264FUSION PROTEINS AND USE THEREOF IN THE TREATMENT OF MEMBRANOUS NEPHROPATHY
#265CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#266IL-2 BASED CONSTRUCTS
#267COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY
#268Virus-like Particles with Programmable Tropism and Methods of Use Thereof for Delivery to Cells
#269ANTI-MUC1-C ANTIBODIES AND CAR-T STRUCTURES
#270HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS
#271BLOCKADE OF CD7 EXPRESSION AND CHIMERIC ANTIGEN RECEPTORS FOR IMMUNOTHERAPY OF T-CELL MALIGNANCIES
#272NUCLEIC ACID MOLECULES ENCODING TRIF AND ADDITIONAL POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#273CHIMERIC ANTIGEN RECEPTORS TARGETING CANCER
#274ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#275CD33 EXON 2 DEFICIENT DONOR STEM CELLS FOR USE WITH CD33 TARGETING AGENTS
#276METHODS TO PROTECT TRANSPLANTED TISSUE FROM REJECTION
#277Method for Producing Antibody-Lysosomal Enzyme Fusion Protein
#278MULTIFUNCTIONAL IMMUNE CELL THERAPIES
#279METHOD TO ENHANCE THE EFFICIENCY OF SYSTEMIC AAV GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM
#280CAR-T CELLS TARGETING IL-1RAP AND THEIR USE
#281RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX
#282Immunotoxins with albumin binding domain
#283TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES
#284CHLAMYDIA TRACHOMATIS ANTIGENIC POLYPEPTIDES AND USES THEREOF FOR VACCINE PURPOSES
#285IMMUNE CELLS EXPRESSING AN ANTIGEN BINDING RECEPTOR AND A CHIMERIC COSTIMULATORY RECEPTOR
#286Compositions and Methods for Treating Cancer with Anti-CD22 Immunotherapy
#287HLA-DR CAR-T COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#288SARS-COV-2 CONSTRUCTS, VACCINES, AND METHODS
#289Immunosuppressive antigen-specific chimeric antigen receptor Treg cells for prevention and/or treatment of autoimmune and alloimmune disorders
#290COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATES AND FAP/4-1BB BINDING MOLECULES
#291COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY
#292FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD
#293Compositions and methods for immunotherapy
#294ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS
#295Artificial Transmembrane Proteins for Detecting Intracellular or Intravesicular Biomolecular Interactions
#296CAR T CELL THERAPIES WITH ENHANCED EFFICACY
#297THERAPEUTIC AGENTS
#298ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATES AND USES THEREOF
#299De novo design of potent and selective interleukin mimetics
#300ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF